Optimize Glaucoma Treatment with Virscio's Intraocular Pressure Modulation Research
Virscio’s Innovative Research Accelerates Development of Glaucoma Therapeutics
Discover how Virscio’s expertise in evaluating Intraocular Pressure (IOP) Modulation can expedite the development of glaucoma therapeutics. Leveraging over 20 years of preclinical experience, Virscio integrates advanced preclinical models, methods, and technologies, focusing on therapeutic innovation and R&D efficiency. Our platform is designed to generate definitive data, reducing the time, cost, and risk associated with therapeutic development across various medical fields including ophthalmology.
In this overview, we focus on Virscio's capabilities to screen IOP lowering candidates, utilizing our scientific and technical expertise in preclinical disciplines. Our comprehensive approach spans from initial study design to execution and reporting, ensuring high-quality research outputs for advancing ophthalmic disease models and other related therapeutic areas.
Learn how Virscio’s advanced research methods in IOP modulation can assist in bringing effective glaucoma treatments to the market more rapidly and safely.
Explore Our IOP Research Now!
Learn how Virscio’s advanced research methods in IOP modulation can assist in bringing effective glaucoma treatments to the market more rapidly and safely.
Virscio's research in IOP modulation is a key component of our dedication to de-risking innovation and offering world-class research capabilities across a range of preclinical disciplines.
In this overview of our IOP Lowering Research, you will learn about:
- Virscio’s cross-over dosing regimen experimental design, including pre-screen IOP measurements, treatment group assignment, and follow-up measurements.
- Measurement techniques and endpoints, such as changes in IOP measured by rebound tonometry and the use of slit lamp examination for efficacy assessment.
- The efficacy of specific therapeutic agents in lowering IOP, demonstrated through significant results in clinical trials using agents like latanoprost and timolol.
Connect with Our Experts: Schedule a Consultation Today!
